About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care

By: via Business Wire

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today released new data showing that its personalized, digital-first approach to weight loss is driving meaningful, sustainable results, laying the groundwork for lasting success. In a first-of-its-kind U.S. analysis of treatment plans, including compounded GLP-1s, customers taking a compounded GLP-1 reported losing an average of 20.9 pounds or 10.3% of initial body weight, within six months, while reporting a low rate of side effects. Just as importantly, 75% of customers remained on treatment plans in the same timeframe, a powerful signal of real-world trust and clinical success.1

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250729936547/en/

Unlike traditional care models that often leave patients to navigate treatment alone, Hims & Hers delivers access to a holistic weight loss program that combines personalized dosing when clinically necessary, 24/7 care team access, and educational support across nutrition, mental health, and physical wellness. The result: a scalable, high-quality model that empowers individuals, builds long-term trust, and helps people succeed.

Unlike traditional care models that often leave patients to navigate treatment alone, Hims & Hers delivers access to a holistic weight loss program that combines personalized dosing when clinically necessary, 24/7 care team access, and educational support across nutrition, mental health, and physical wellness. The result: a scalable, high-quality model that empowers individuals, builds long-term trust, and helps people succeed.

Unlike traditional care models that often leave patients to navigate treatment alone, Hims & Hers delivers access to a holistic weight loss program that combines personalized dosing when clinically necessary, 24/7 care team access, and educational support across nutrition, mental health, and physical wellness. The result: a scalable, high-quality model that empowers individuals, builds long-term trust, and helps people succeed.

Key findings from the new analysis indicate:

  • Holistic model helps people stick with their treatment: While dropout rates for commercially available GLP-1s can hover around 80% at six months2, only 25% of Hims & Hers customers discontinued treatment in that timeframe, highlighting the strength and confidence a holistic, personalized model delivers. While these results cannot be directly compared, it is encouraging that Hims & Hers customers appear to stick to their treatment plans in high numbers.
  • Personalized treatment plans drive significant weight loss, with low rates of side effects and high safety: Customers lost an average of 20.9 pounds, or 10.3% of their initial body weight in six months. Among these same customers, only 10.3% reported side effects, and an even smaller 4.5% reported intolerable side effects. Among those who completed a 6-month check-in, 97% of customers on plans with compounded GLP-1s reported an improvement in their overall health.
  • Always-on support empowers customers beyond the prescription: The platform combines 24/7 care team access with curated education across nutrition, mental health, and physical wellness. Customers exchanged over 6.7 million messages with their care teams, with 75% receiving responses in 5 hours or less3. In fact, the majority of customers (73%) preferred their digital health experience with Hims & Hers over other programs or providers4.
  • Care in hours, not months, designed to scale without compromise: The average wait time to see an obesity medicine specialist in the U.S. is approximately 5 months5. In contrast, the average wait time for a Hims & Hers Weight Loss customer to have their online medical intake evaluated by a licensed provider is approximately 3 hours.6

"My two decades as an obesity medicine specialist have shown me that lasting weight loss hinges on treating the individual, not just the condition. The true power of Hims & Hers lies in our ability to deliver access to truly bespoke care: from personalized dosing and tailored nutritional guidance to 24/7 access to reach out to their care team,” said Craig Primack MD, Head of Weight Loss, Hims & Hers. “Medication is a powerful component, but it's just one part of the comprehensive support system people need for this transformative health journey. Today's findings strongly signal that a digital-first, personalized experience is precisely what helps people stick to their treatment plans to drive lasting outcomes."

Download the full white paper here.

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.com and www.forhers.com.

____________________

1

Hims & Hers evaluated de-identified data from 13,458 Weight Loss customers prescribed a compounded injectable GLP-1 medication through our platform who completed a 6-month check. — Hims & Hers, The 1-Year Journey of Hims & Hers Weight Loss Customers, White Paper, 2025.

2

Blue Health Intelligence. (2024). Real-world trends in GLP-1 treatment persistence and prescribing for weight management. https://www.bcbs.com/media/pdf/BHI_Issue_Brief_GLP1_Trends.pdf

3

Hims & Hers Internal Data, as of June 30, 2025

4

Hims & Hers Customer Insights and User Experience Weight Loss Survey, July 2025

5

Rustagi, R. (2023). Regional disparities in access to obesity care: Analysis of wait times in top U.S. hospitals [conference presentation]. World Obesity and Weight Management Congress 2023. Boston, MA. https://obesityworldconference.com/program/scientific-program/2023/regional-disparities-in-access-to-obesity-care-an-analysis-of-wait-times-in-top-u-s-hospitals

6

Hims & Hers Internal Data, as of June 30, 2025

 

Contacts

More News

View More
3 Healthcare Stocks Using AI to Drive Growth
Via MarketBeat
Topics Artificial Intelligence
Tickers BSX HIMS TEM
Get Exposure to Millennials' Purchasing Power With This ETF
Via MarketBeat
Topics ETFs
Tickers AAPL DASH DIS GOOGL META MILN
Why a $4.5 Billion Smart Debt Move Is Fueling Dell’s AI Ambitions
Via MarketBeat
Topics Artificial Intelligence
Tickers DELL
Beam Global Gets Buy Rating With 101% Upside Potential
Via MarketBeat
Topics Intellectual Property
Tickers BEEM
These 3 Crypto Stocks Could Get a Bump as Dollar Trust Weakens
Via MarketBeat
Topics ETFs Economy World Trade
Tickers BITF COIN HOOD
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.